News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • FERC approved Blackstone's acquisition of TXNM Energy, removing a major federal regulatory hurdle.
  • JFrog shares fell over 20% after Anthropic unveiled Claude Code Security; Raymond James maintained an Outperform rating.
  • Analyst recommends a 180-day short on Coupang, citing prolonged financial fallout from its major data breach.
  • White House exempted most USMCA goods from the new 10% global tariff, reducing immediate tariff exposure for Canada and Mexico.
  • Blue Owl failed to secure $4 billion for a Lancaster data center due to CoreWeave's B+ credit, leaving a $500 million bridge loan exposure.

Latest Articles

Indonesia to Release $11 Billion in Shares as Free-Float Rule Widens

Indonesia to Release $11 Billion in Shares as Free-Float Rule Widens

Jakarta’s planned capital market reforms, prompted by an MSCI warning over market opacity, would require 267 companies on the Indonesia Stock Exchange to increase public shareholdings to a 15% minimum free float. If none delist, these companies would need to put roughly 187 trillion rupiah ($11.08 billion) of shares on the market, posing a notable …

Jefferies Raises CoStar to Buy Citing Homes.com Upside and Margin Leverage

Jefferies Raises CoStar to Buy Citing Homes.com Upside and Margin Leverage

Jefferies upgraded CoStar Group (CSGP) from Hold to Buy and lowered its price target to $67 from $84, citing what it describes as an attractive entry valuation tied to the ongoing debate over Homes.com. The firm projects above-guidance revenue growth and sharply expanding adjusted EBITDA margins through 2030, while activist investor criticism has a…

Catena posts modest beat on earnings but disappoints on dividend target

Catena posts modest beat on earnings but disappoints on dividend target

Catena AB reported full-year 2025 results with EPRA earnings per share of SEK25.62, slightly above analyst estimates, supported by rising rental income and net operating surplus. The board proposed a dividend increase to SEK9.5 per share that nonetheless missed market expectations by about 6%. A large portfolio acquisition will lift leverage metric…

European equities inch higher as earnings wrap up and retail sales surprise; oil firmer on Middle East tensions

European equities inch higher as earnings wrap up and retail sales surprise; oil firmer on Middle East tensions

European stocks moved modestly higher on Friday as investors parsed a late wave of corporate results and economic releases, while geopolitical tensions between the U.S. and Iran lent support to oil prices. German, French and U.K. benchmarks all advanced in early trading. Corporate reports from miners to drugmakers provided mixed signals, U.K. retai…

HSBC Lowers TechnipFMC to Hold but Increases Price Target to $62

HSBC Lowers TechnipFMC to Hold but Increases Price Target to $62

HSBC moved TechnipFMC from Buy to Hold while raising its 12-month price target to $62 from $49. The change follows a set of mixed quarterly and strong annual results: fourth-quarter revenue and margins dipped sequentially, but full-year 2025 revenue and adjusted EBITDA margins improved. Share repurchases slowed in the quarter despite a new $2 billi…

Chemring Upholds FY26 Guidance as Order Cover Climbs to 85%

Chemring Upholds FY26 Guidance as Order Cover Climbs to 85%

Chemring Group PLC has maintained its FY26 guidance as of the end of January 2026, reporting a modest increase in its order book and a rise in group order cover to 85%. While total orders advanced slightly to £1.364bn, first-quarter order intake dropped to £122m, reflecting the absence of the multi-year contracts that lifted Q1 2025 results. Divisi…

ALK-Abello Posts Q4 Beats, Proposes First Dividend Since 2017

ALK-Abello Posts Q4 Beats, Proposes First Dividend Since 2017

ALK-Abello reported fourth quarter sales and operating profit above consensus, driven by stronger-than-expected European tablet sales and Other Products. The Danish biotechnology firm proposed a DKK1.6 per share dividend, its first since 2017, and issued 2026 revenue and margin guidance while confirming leadership changes in research and developmen…

Equitable Holdings CEO Sells $1.8M in Stock Ahead of Notable Revenue Miss

Equitable Holdings CEO Sells $1.8M in Stock Ahead of Notable Revenue Miss

Equitable Holdings President and CEO Mark Pearson sold 39,700 shares on February 18, 2026, for about $1.8 million while also exercising options to acquire 27,200 shares at $23.18. The stock is trading below recent highs and InvestingPro flags the equity as appearing overvalued. Separately, Equitable reported Q4 2025 EPS in line with expectations bu…

FDA Clears All-Oral Calquence and Venetoclax Regimen for CLL and SLL

FDA Clears All-Oral Calquence and Venetoclax Regimen for CLL and SLL

The U.S. Food and Drug Administration has approved AstraZeneca’s Calquence (acalabrutinib) in combination with venetoclax as the first all-oral, fixed-duration regimen for adults with chronic lymphocytic leukaemia (CLL) and small lymphocytic lymphoma (SLL). The decision is grounded in results from the AMPLIFY Phase III trial, which demonstrated hig…

Gentex VP Disposes Nearly $500k in Stock While Retaining Substantial Stake

Gentex VP Disposes Nearly $500k in Stock While Retaining Substantial Stake

Gentex Vice President of Sales Matthew Chiodo sold 19,827 shares on February 17, 2026, for about $496,170, while also recording zero-price acquisitions and tax-related share withholdings in filings with the SEC. The transactions leave Chiodo with 47,148 shares. Separately, Gentex posted a slight EPS beat but a marginal revenue shortfall for Q4 2025…